The company IPOed in 2011

GizaVC invests in the vision of Israel's most innovative entrepreneurs.



IceCure Medical develops innovative, minimally invasive products for the treatment of breast tumors and other internal diseased tissue. It focuses on benign (non-cancerous) tumors, especially fibroadenoma in the women’s health space. Treatment is based on disruptive cryosurgery technology, which is reliable and safe and saves surgical, hospitalization, recovery and rehabilitation costs.

icecure c



Dr. Alexander Levin, Rafi Klein, Didier Toubia


CEO:  Hezi Himelfarb         CTO: Nir Berzak

CFO: Meirav Dudek     

Giza's Handler

Yuval Avni, Elka Nir (Chairperson)


Fields of invesment: icon lifeHealthcare

Contact info: Website